Referencias

1.     Schlaeder G, Messer J, Haddad J, Langer B. Medicina Fetale e Neonatale. Roma, CIC Edizioni Internazionali, 1995; 231.

2.     Goldman L, Claude Bennett J. Cecil. Tratado de Medicina Interna, 21 ed. Madrid, McGraw-Hill. Interamericana 2002, Vol. II, 2082-2141.

3.     Montano M, Rarick M, Sebastiani P, Brinkmann P, Russell M, Navis A et al. Gene expression profiling of HIV-1 infection and perinatal transmission in Botwswana. Genes Immu 2006; 7:298-309.

4.     Bulterys M. HIV during pregnancy. Preventing vertical HIV transmission in the year 2000: Progress and Prospect-A review. Trophoblast Research 2001; 15:S5-S12.

5.     D’Costa GF, KhadKe K, Patil YV. Pathology of placenta in HIV infection. Indian J Pathol Microbiol 2007; 50:515-519.

6.     Miller RK, Ebbensen P, Popek EJ, Polliotti B, Sleikh A, Roberts D et al. The role of the placenta in the vertical transmission of HIV and other infection agents - A Workshop Report. Trophoblast Research 1998; 12:225-235.

7.     Jauniaux E, Nesmann C, Imbert MC, Meuris S, Puissant F, Hustin J. Morphological aspects of the placentas of HIV pregnancies. Placenta 1998; 9:633-642.

8.     Connor EM, Sperling RS, Golber R, Kiselev P, Scott G, O’ Sullivan MJ et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180.

9.     Benirschke K, Kaufmann P. Pathology of the human placenta. 4th edition. New York, Springer-Verlag, 2000.

10.   Lewis SH, Perrin E. Pathology of the placenta. New York, Churchill Livingstone, 1999.

11.   Corcoran C, Ryan L, Senchandhuri P, Metha C, Patel N, Molenberghs G. An exact trend test for correlated binary data. Biometrics 2001; 57: 941-948.

12.   Cytel. Statact 8.User Manual. Cambridge, Cytel software, 2007; 1303.

13.   Unger M, Jimenez E, Backe E, Vogel M, Shafer A, Friedmann W. Allantois vasculopathy of the placenta in HIV-exposed pregnancies: correlation to clinical findings. Int Conf AIDS 1990; 6:191.

14.   Backe E, Jimenez E, Unger M, Schafer A, Vocks-Hauck M, Grosch-Wömer I et al. Vertical human immunodeficiency virus transmission: a study of the placental pathology in relation to maternal risk factors. Am J Perinatol 1994; 11:326-330.

15.   Fauci AS, Lane CH, Enfermedad por el virus de la inmunodeficiencia humana: SIDA y procesos relacionados. En: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrinson. Principios de Medicina Interna.14ed. Mexico, McGraw-Hill, 1998, Vol. II, 2034-2107.

16.   Hürlimann D, Weber R, Enseleit F, Luscher TF. HIV infection, antiretroviral therapy, and endothelium. Herz 2005; 30:472-480.

17.   Castejón O, Belouche R, Morett V. El proceso de calcificación en la placenta humana. Gac Med Caracas 1998; 106:496-501.

18.   Jiang B, Hebert VY, Li Y, Mathis JM, Alexander JS, Dugas TR. HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis. Toxicol Appl Pharmacol 2007; 224:60-71.

19.   Wimalasundera RC, Larbalestier N, Smith JH. Pre-eclampsia, antiretroviral therapy and immune reconstitution. Lancet 2002; 360:1152-1154.

20.   Levario CM, Feria V, De Celis R, Ramos ME, Cordova FL, Solis FJ. Parathion, a cholinesterase-inhibiting plaguicide induces changes in tertiary villi of placenta of women exposed: a scanning electron microscopy study. Gynecol Obstet Invest 2001; 52:269-275.

21.   Dreyfuss ML, Fawzy WW. Micronutrients and vertical transmission of HIV-1. Am J Clin Nutrit 2002; 75:959-970.

22.   Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8:110-124.